What Researchers Did
Researchers studied 80 patients with acute spinal cord injury from thoracolumbar fractures, comparing conventional postoperative care to a combination of riluzole, mannitol, and hyperbaric oxygen therapy.
What They Found
Both groups showed improved motor and sensory function after treatment. However, the group receiving riluzole, mannitol, and hyperbaric oxygen showed significantly greater improvements in motor and sensory function compared to the control group (p<0.05). This combined therapy also led to significantly lower levels of inflammatory markers (IL-6) and growth factors (BDNF, NFGF) in the experimental group (p<0.05).
What This Means for Canadian Patients
For Canadian patients experiencing acute spinal cord injury due to thoracolumbar fractures, this study suggests that adding riluzole, mannitol, and hyperbaric oxygen to conventional care could lead to better recovery of movement and sensation. This approach may also help reduce inflammation in the spinal cord, potentially improving long-term outcomes for this severe condition.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This study was conducted at a single hospital with a relatively small number of patients and a short follow-up period of four weeks.